112953 ⎘
Oligonucleotides characterized by their use Polymorphic or mutational markers
DIFFERENTIATION MARKER GENE SET, METHOD, AND KIT FOR DIFFERENTIATING OR CLASSIFYING SUBTYPE OF BREAST CANCER
#2102METHOD FOR CONDUCTING EARLY DETECTION OF COLON CANCER AND/OR OF COLON CANCER PRECURSOR CELLS AND FOR MONITORING COLON CANCER RECURRENCE
#2103METHODS AND KITS FOR INFERTILITY DIAGNOSTICS
#2104PROBE-INDUCED HETERODUPLEX MOBILITY ASSAY
#2105PCR-Activated Sorting (PAS)
#2106Alteration of tobacco alkaloid content through modification of specific cytochrome P450 genes
#2107Checkpoint blockade and microsatellite instability
#2108Clonal Hematopoiesis and Risk of Chronic Liver Disease
#2109Adeno-associated viral chimeric TDP-43 proteins
#2110High-Throughput Identification of Patient-Specific Neoepitopes as Therapeutic Targets for Cancer Immunotherapies
#2111LONGITUDINAL MOLECULAR DIAGNOSTICS DETECT SOMATIC REVERSION MUTATIONS
#2112EGFR AND ROS1 KINASE IN CANCER
#2113TRANSPLANT PATIENT MONITORING WITH CELL-FREE DNA
#2114DETECTION AND QUANTIFICATION OF RARE VARIANTS WITH LOW-DEPTH SEQUENCING VIA SELECTIVE ALLELE ENRICHMENT OR DEPLETION
#2115METHODS FOR IDENTIFYING CARRIER STATUS AND ASSESSING RISK FOR SPINAL MUSCULAR ATROPHY
#2116MOLECULAR MARKER COMBINATION LINKED TO QUANTITATIVE TRAITS OF TEA PLANT CAFFEINE CONTENT
#2117MOLECULAR MARKER COMBINATION LINKED TO QUANTITATIVE TRAITS OF TEA PLANT (+)-CATECHIN CONTENT
#2118DETECTION OF GENOMIC SEQUENCES USING COMBINATIONS OF PROBES, PROBE MOLECULES AND ARRAYS COMPRISING THE PROBES FOR THE SPECIFIC DETECTION OF ORGANISMS
#2119Genetic locus imparting a low anatabine trait in tobacco and methods of using
#2120HSD17B13 variants and uses thereof
#2121Peptides and combination of peptides for use in immunotherapy against various cancers
#2122Peptides and combination of peptides for use in immunotherapy against various cancers
#2123Peptides and combination of peptides for use in immunotherapy against various cancers
#2124METHODS FOR USE OF GENE EXPRESSION AS AN INDICATOR OF E-SELECTIN INHIBITOR EFFICACY AND CLINICAL OUTCOME FOR MULTIPLE TUMOR TYPES
#2125METHOD AND COMPOSITIONS FOR THE TREATMENT AND DETECTION OF ENDOTHELIN-1 RELATED KIDNEY DISEASES
#2126Assays for the Detection of SARS-CoV2 Mutants
#2127Estimating tumor purity from single samples
#2128GENE SIGNATURES FOR CANCER PROGNOSIS
#2129COMPOSITIONS AND METHODS FOR TREATING BREAST CANCER
#2130RAPID ANEUPLOIDY DETECTION
#2131SYSTEMS AND METHODS FOR CELL OF ORIGIN DETERMINATION FROM VARIANT CALLING DATA
#2132COMBINED AUXILIARY DIAGNOSTIC METHOD, KIT, SYSTEM AND USE OF POINT MUTATION AND METHYLATION OF BLADDER CANCER DRIVER GENES
#2133METHODS FOR THE ADMINISTRATION OF ILOPERIDONE
#2134COMPOSITIONS AND METHODS FOR XI CHROMOSOME REACTIVATION
#2135COTTON TRANSGENIC EVENT MON 88702 AND METHODS FOR DETECTION AND USES THEREOF
#2136Checkpoint blockade and microsatellite instability
#2137Peptides and combination of peptides for use in immunotherapy against various cancers
#2138Peptides and combination of peptides for use in immunotherapy against various cancers
#2139Estrogen receptor mutations and uses thereof
#2140MUTANT CALRETICULIN FOR THE DIAGNOSIS OF MYELOID MALIGNANCIES
#2141Methods of determining responsiveness to anti-TNFα therapy in inflammatory bowel disease
#2142Methods for detecting immune cell DNA and monitoring immune system
#2143Methods of characterizing resistance to modulators of Cereblon
#2144COLD-TOLERANT PLANT
#2145BOVINE MONOCYTE-DERIVED MACROPHAGE IN CULTURE SYSTEM AND METHODS FOR MEASURING INNATE IMMUNITY
#2146METHODS AND COMPOSITIONS FOR CANCER TREATMENT AND TREATMENT SELECTION
#2147COMPOSITIONS AND METHODS FOR TREATING LUNG, COLORECTAL AND BREAST CANCER
#2148Peptides and combination of peptides for use in immunotherapy against various cancers
#2149Peptides and T cells for use in immunotherapeutic treatment hepatocellular carcinoma
#2150Peptides and T cells for use in immunotherapeutic treatment of various cancers
#2151GINS2 peptide and T cells for use in immunotherapeutic treatment of various cancers
#2152Treatment and detection of inherited neuropathies and associated disorders
#2153TREATMENT AGENT FOR SEX HORMONE-INSENSITIVE GREB1-POSITIVE TUMORS
#2154METHODS FOR PREDICTING RESPONSIVENESS OF CANCER TO FERROPTOSIS-INDUCING THERAPIES
#2155METHODS OF ASSESSING RISK OF DEVELOPING A SEVERE RESPONSE TO CORONAVIRUS INFECTION
#2156Optimal selection method of gene chip probes for cancer screening
#2157MATERIALS AND METHODS FOR DETERMINING CANCER RISK
#2158BREAST CANCER DETECTION METHODS
#2159DROUGHT TOLERANCE IN CORN
#2160MOLECULAR MARKER, GENE OF MAIZE EAR ROT RESISTANCE AND USE THEREOF
#2161SYSTEMS AND METHODS FOR EVALUATING TUMOR FRACTION
#2162METHODS OF DETECTING CANCER
#2163GENES AND GENE SIGNATURE FOR DIAGNOSIS AND TREATMENT OF MELANOMA
#2164ASSESSING RISK OF READING AND LANGUAGE IMPAIRMENT
#2165Spatial indexing of genetic material and library preparation using hydrogel beads and flow cells
#2166MARKERS FOR IDENTIFYING AND QUANTIFYING OF NUCLEIC ACID SEQUENCE MUTATION, EXPRESSION, SPLICE VARIANT, TRANSLOCATION, COPY NUMBER, OR METHYLATION CHANGES
#2167DETERMINING THE DNA PRESENT IN A CELL BY IMAGING AND MATCHED FILTERING
#2168METHODS FOR TREATING METABOLIC DISORDERS BY TARGETING ADCY5
#2169Methods of determining sensitivity to photoperiod in cannabis
#2170A METHOD FOR DETERMINING A YEAST HAVING EXTRACELLULAR GLUCOAMYLASE STA1p ACTIVITY IN A SAMPLE AND TOOLS AND USES RELATED THERETO
#2171Method for Classifying a Patient's Responsiveness to Immune Checkpoint Inhibitor Therapy
#2172COMPOSITIONS AND METHODS FOR ISOLATING, DETECTING, AND ANALYZING FETAL CELLS
#2173Use of Biomarkers for Degenerative Disc Disease
#2174POLYNUCLEOTIDES, PRIMERS, AND METHODS FOR DETECTION OF TRANSGENIC EVENT, GENETIC CONSTRUCT, KIT FOR DETECTION MATERIAL FROM A PLANT SAMPLE, EVENT CTC91087-6, INSECT-RESISTANT SUGARCANE PLANT, AND METHOD FOR PRODUCING AN INSECT-RESISTANT SUGARCANE PLANT, PLANT CELL, PLANT PART OR SEED
#2175COMPOSITIONS AND METHODS FOR IDENTIFYING AND INHIBITING A PAN-CANCER CELLULAR TRANSITION OF ADIPOSE-DERIVED STROMAL CELLS
#2176NOVEL ADP-RIBOSYL CYCLASE AND INHIBITOR THEREOF
#2177PEPTIDES AND T CELLS FOR USE IN IMMUNOTHERAPEUTIC TREATMENT OF VARIOUS CANCERS
#2178PEPTIDES AND T CELLS FOR USE IN IMMUNOTHERAPEUTIC TREATMENT OF VARIOUS CANCERS
#2179IMMUNOGENETIC CANCER SCREENING TEST
#2180METHODS OF TREATING URINARY SYSTEM CANCERS
#2181DIAGNOSIS, PROGNOSIS AND TREATMENT FOR SCHIZOPHRENIA AND SCHIZOAFFECTIVE PSYCHOSIS
#2182Two PARMS-SNP Molecular Markers for Identifying Resistant Gene VrTAF5 of Vigna radiata (Linn.) Wilczek Cercospora Leaf Spot Disease
#2183SNP MARKER COMBINATION AND IDENTIFICATION METHOD FOR PUDONG WHITE PIGS AND RAW MEAT PRODUCTS
#2184Cancer stratification and treatment based on Inhibition of NOD-2
#2185Diagnostics and Treatments Based Upon Molecular Characterization of Colorectal Cancer
#2186Methods, Compositions, and Systems for Detecting Silent Carriers of Spinal Muscular Atrophy
#2187Method of Determining Disease Causality of Genome Mutations
#2188MAJOR HISTOCOMPATIBILITY COMPLEX SINGLE NUCLEOTIDE POLYMORPHISMS
#2189POLYMORPHIC MARKERS FOR PHARMACOGENETIC HLA RISK ALLELES
#2190NMR METHODS AND SYSTEMS FOR THE RAPID DETECTION OF TICK-BORNE PATHOGENS
#2191GENETIC LOCUS FOR REGULATING THCAS ACTIVITY IN CANNABIS SATIVA L.
#2192METHODS AND COMPOSITIONS FOR PRODUCING VITAMIN K DEPENDENT PROTEINS
#2193Method for treating non-small lung cancer with a population of activated cells
#2194Peptides and T cells for use in immunotherapeutic treatment of various cancers
#2195Methods of Treating Cancer Using CHK1 Inhibitors
#2196OPTIMIZED SIGMA-1 AGONIST METHOD OF RESPONDER SELECTION AND TREATMENT
#2197Compositions and methods for minimizing nornicotine synthesis in tobacco
#2198Broad-Spectrum Nanoparticle Enabled Genomic Detection
#2199Method for identifying racehorse using microsatellite marker
#2200EXTRACHROMOSOMAL DNA IDENTIFICATION AND METHODS OF USE
#2201IMPROVED METHODS FOR THE EARLY DIAGNOSIS OF UTERINE LEIOMYOMAS AND LEIOMYOSARCOMAS
#2202Head and neck squamous cell carcinoma assays
#2203METHODS AND SYSTEMS FOR PROGNOSIS OF A PATIENT'S RESPONSE TO TREATMENT OF ANDROGENETIC SKIN DISORDERS
#2204Use of Cystatin SN in Detecting Chronic Rhinosinusitis with Nasal Polyps Subtype and Predicting Sensitivity of Patient to Glucocorticoid
#2205Downy Mildew Resistant Spinach Plant
#2206MODULATORS OF TELOMERE DISEASE
#2207TARGETED THERAPY
#2208CRENOLANIB FOR TREATING FLT3 MUTATED PROLIFERATIVE DISORDERS ASSOCIATED MUTATIONS
#2209HIGH THROUGHPUT CASSETTE FILLER
#2210DETECTION AND TREATMENT OF DISEASE EXHIBITING DISEASE CELL HETEROGENEITY AND SYSTEMS AND METHODS FOR COMMUNICATING TEST RESULTS
#2211METHODS AND SYSTEMS FOR URINE-BASED DETECTION OF UROLOGIC CONDITIONS
#2212PRKC FUSIONS
#2213METHODS FOR DIAGNOSIS AND PROGNOSIS OF PROSTATE CANCER
#2214A METHOD FOR DIAGNOSING CANCERS OF THE GENITOURINARY TRACT
#2215NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC AND OTHER CANCERS
#2216METHODS FOR TREATING PTEN-MUTANT TUMORS
#2217Methods and systems for analyzing nucleic acid molecules
#2218COMPOSITION OF PRIMERS FOR DETECTING HIGH GRADE SQUAMOUS INTRAEPITHELIAL LESION
#2219Combination of Soybean Whole Genome SNP Loci, Gene Chip and Application Thereof
#2220Systems and methods to detect rare mutations and copy number variation
#2221METHOD AND MARKERS FOR IDENTIFYING AND QUANTIFYING OF NUCLEIC ACID SEQUENCE, MUTATION, COPY NUMBER, OR METHYLATION CHANGES
#2222ASSAYING OVARIAN CYST FLUID
#2223METHODS AND MATERIALS FOR ASSESSING LOSS OF HETEROZYGOSITY
#2224RAF1 FUSIONS
#2225Primers for Diagnosing Avellino Corneal Dystrophy
#2226DETECTING CANCER RISK
#2227A METHOD TO PREDICT THE PREDISPOSITION TO AN EXERCISE PERFORMANCE TRAIT IN A HUMAN INDIVIDUAL
#2228MELTING TEMPERATURE METHODS, KITS AND REPORTER OLIGO FOR DETECTING VARIANT NUCLEIC ACIDS
#2229SE33 mutations impacting genotype concordance
#2230TREATMENT OF H-RAS-DRIVEN TUMORS
#2231GENETIC VARIANTS ASSOCIATED WITH RESPONSE TO TREATMENT OF NEUROLOGICAL DISORDERS
#2232Stevia plant having less ability to form flower buds
#2233BCR-ABL variants
#2234Marker composition for diagnosing or predicting prognosis of lung cancer based on exosome overexpressing GCC2 gene or protein
#2235METHODS AND COMPOSITIONS TO SELECT AND/OR PREDICT COTTON PLANTS RESISTANT TO FUSARIUM RACE-4 RESISTANCE IN COTTON
#2236METHOD AND KIT FOR DETECTING RISK OF COLORECTAL CANCER
#2237EXOSOMES CONTAINING RNA WITH SPECIFIC MUTATION
#2238IDENTIFICATION AND USE OF CIRCULATING NUCLEIC ACID TUMOR MARKERS
#2239ISOFORMS OF GATA6 AND NKX2-1 AS MARKERS FOR DIAGNOSIS AND THERAPY OF CANCER AND AS TARGETS FOR ANTI-CANCER THERAPY
#2240PROBE/PRIMER LIBRARY FOR DIAGNOSIS OF CANCER
#2241SYSTEM AND METHOD FOR CLEANING NOISY GENETIC DATA AND DETERMINING CHROMOSOME COPY NUMBER
#2242tRNA-Derived Fragments as Disease Biomarkers and Neuropathological Regulators in Alzheimer's Disease
#2243METHOD FOR MODIFYING THE RESISTANCE PROFILE OF SPINACIA OLERACEA TO DOWNY MILDEW
#2244Methods for isolating cell-free DNA
#2245NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC AND OTHER CANCERS
#2246USE OF SUBSTITUTED HEXITOLS INCLUDING DIANHYDROGALACTITOL AND ANALOGS TO TREAT NEOPLASTIC DISEASE AND CANCER STEM CELLS INCLUDING GLIOBLASTOMA MULTIFORME AND MEDULLOBLASTOMA
#2247DISEASE RESISTANT PLANT METHODS AND COMPOSITIONS
#2248MOLECULAR MARKERS RELATED TO MUTATION OF COARSE WOOL RATE AND WOOL FIBER DIAMETER OF LONG-HAIRED RABBIT AND USE THEREOF
#2249Methods for early detection of cancer
#2250MARKER FOR HOMOLOGOUS RECOMBINATION DEFICIENCY, METHOD AND SYSTEM FOR DETECTION THEREOF
#2251METHODS FOR PREDICTING ANTI-CANCER RESPONSE
#2252METHOD FOR DIAGNOSING CELIAC DISEASE BASED ON THE LEVEL OF EXPRESSION OF THE UBE2L3 GENE
#2253MOLECULAR MARKER RELATED TO WOOL YIELD OF LONG-HAIRED RABBIT AND USE THEREOF
#2254CANNABIS PLANTS WITH IMPROVED YIELD
#2255Pesticidal genes and methods of use
#2256NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC AND OTHER CANCERS
#2257NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC AND OTHER CANCERS
#2258USE OF KDM5A GENE AND ATRX GENE
#2259COLORECTAL CANCER CONSENSUS MOLECULAR SUBTYPE CLASSIFIER CODESETS AND METHODS OF USE THEREOF
#2260EARLY DETECTION AND PREDICTION METHOD OF PAN-CANCER
#2261Methods Of Identifying Subjects Having An Increased Risk Of Developing A Coronavirus Infection And Treatment Thereof
#2262METHODS OF PREDICTING AND PREVENTING CANCER IN PATIENTS HAVING PREMALIGNANT LESIONS
#2263METHOD OF MONITORING TREATMENT
#2264METHODS, KITS, AND DEVICES FOR DIAGNOSING, PROGNOSING, AND TREATING PSYCHIATRIC DISORDERS IN A PATIENT
#2265Methods for detecting an increased risk for coronary heart disease
#2266METHODS FOR DETECTING OR REDUCING THE INCIDENCE OF ADVERSE DRUG REACTIONS
#2267GENETIC RISK ANALYSIS FOR POST-TRAUMATIC STRESS DISORDERS AND BEHAVIORAL MANAGEMENT THEREOF
#2268METHODS AND COMPOSITIONS FOR PRODUCING ACTIVE VITAMIN K-DEPENDENT PROTEINS
#2269EX VIVO METHODS FOR PRODUCING A T CELL THERAPEUTIC AND RELATED COMPOSITIONS AND METHODS
#2270Peptides and T cells for use in immunotherapeutic treatment of various cancers
#2271FGFR TYROSINE KINASE INHIBITORS FOR THE TREATMENT OF UROTHELIAL CARCINOMA
#2272Methods of Treating Ovarian Cancer
#2273Methods of Treating Ovarian Cancer
#2274PHOSPHATIDYLINOSITOL-3-KINASE PATHWAY BIOMARKERS
#2275METHODS FOR DIAGNOSIS AND PROGNOSIS OF PROSTATE CANCER
#2276GENOTYPING KIT FOR DETECTION OF SIX CD36 MUTANT GENES THAT ENCODE GPIV DEFICIENCY
#2277METHOD FOR DETECTING SMN GENE COPY NUMBER USING SMNP AS REFERENCE
#2278METHOD FOR IDENTIFYING DISEASE-ASSOCIATED CDR3 PATTERNS IN AN IMMUNE REPERTOIRE
#2279Methods of identifying and treating a person having a predisposition to or afflicted with a cardiometabolic disease
#2280BIOMARKER COMPOSITION, DIAGNOSTIC KIT, AND METHOD FOR PROVIDING INFORMATION
#2281SEQUENCES FOR DETECTION AND IDENTIFICATION OF METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS (MRSA) OF MREJ TYPE XXI
#2282OLIGONUCLEOTIDE PROBES AND USES THEREOF
#2283Alpha-1 antitrypsin (AAT) RNAi agents, compositions including AAT RNAi agents, and methods of use
#2284Methods and Compositions for Producing Brachytic Corn Plants
#2285COMPOSITION FOR DIAGNOSIS OR PROGNOSIS PREDICTION OF GLIOMA, AND METHOD FOR PROVIDING INFORMATION RELATED THERETO
#2286Computational method for detecting fusion events
#2287INTRA-PATIENT GENOMIC HETEROGENEITY OF SINGLE CIRCULATING TUMOR CELLS (CTCS) ASSOCIATED TO PHENOTYPIC CTC HETEROGENEITY IN METASTATIC CASTRATE RESISTANT PROSTATE CANCER (MCRPC)
#2288METHODS OF PREPARING MICROVESICLE MICRORNAS FROM BODILY FLUIDS
#2289METHODS OF DIAGNOSING INFLAMMATORY BOWEL DISEASE THROUGH RNASET2
#2290Humanized anti-DKK2 antibody and uses thereof
#2291Peptides and T cells for use in immunotherapeutic treatment of various cancers
#2292Method for the treatment of Dravet Syndrome
#2293SYSTEMS, COMPOSITIONS, AND METHODS FOR TARGET ENTITY DETECTION
#2294USE OF ANTI-PD-1 ANTIBODY IN PREPARATION OF MEDICAMENT FOR TREATING SOLID TUMORS
#2295METHODS AND MATERIALS FOR ASSESSING AND TREATING CANCER
#2296METHODS AND COMPOSITIONS FOR DETECTING ESOPHAGEAL NEOPLASIAS AND/OR METAPLASIAS IN THE ESOPHAGUS
#2297NORMALIZING TUMOR MUTATION BURDEN
#2298COMBINED ANALYSIS OF CELL-FREE NUCLEIC ACIDS AND SINGLE CELLS FOR ONCOLOGY DIAGNOSTICS
#2299Compositions and methods for analyzing DNA using partitioning and base conversion
#2300ANALYSIS OF METHYLATED DNA COMPRISING METHYLATION-SENSITIVE OR METHYLATION-DEPENDENT RESTRICTIONS
#2301Genetic polymorphisms associated with coronary events and drug response, methods of detection and uses thereof
#2302System and Methods for Detection of Low-Copy Number Nucleic Acids and Protein
#2303METHOD FOR DETERMINING SIDE EFFECTS OF TRASTUZUMAB AND KIT FOR SAME
#2304Kit comprising contiguous nucleobases, including position 76, of RS5745994
#2305NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST PROSTATE CANCER AND OTHER CANCERS
#2306Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers
#2307Agents and methods for treating pancreatic ductal adenocarcinomas
#2308MARKERS OF EFFICACY OF TOPOISOMERASE POISONS
#2309Use of pooled samples to optimise the efficiency and utility of a rapid, lab-free point-of-care test
#2310METHOD OF CLASSIFYING A SAMPLE BASED ON DETERMINATION OF FGFR
#2311KIT FOR EARLY SCREENING OF LIVER CELL CANCER AND PREPARATION METHOD AND USE THEREOF
#2312METHOD OF IDENTIFYING PATIENTS WITH BORTEZOMIB RESISTANT MULTIPLE MYELOMA AND OTHER BLOOD DISEASES
#2313Transpochimeric Gene Transcripts (TCGTS) As Cancer Biomarkers
#2314METHODS OF IDENTIFYING SNPS CORRELATING WITH ELITE ATHLETIC PERFORMANCE
#2315COST-EFFECTIVE DETECTION OF LOW FREQUENCY GENETIC VARIATION
#2316Methods and kits to identify strains
#2317EARLY DETECTION OF DRUG-RESISTANT MYCOBACTERIUM TUBERCULOSIS
#2318METHOD AND SYSTEM FOR PREDICTING RESPONSE OF A SUBJECT TO ANTIDEPRESSANT TREATMENT
#2319Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers
#2320NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST PROSTATE CANCER AND OTHER CANCERS
#2321Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers
#2322COMPOUNDS WITH ANTI-TUMOR ACTIVITY AGAINST CANCER CELLS BEARING EGFR OR HER2 EXON 20 INSERTIONS
#2323METHODS OF TREATING CANCER WITH FARNESYLTRANSFERASE INHIBITORS
#2324USE OF SUBSTITUTED HEXITOLS INCLUDING DIANHYDROGALACTITOL AND ANALOGS TO TREAT NEOPLASTIC DISEASE AND CANCER STEM CELLS INCLUDING GLIOBLASTOMA MULTIFORME AND MEDULLOBLASTOMA
#2325METHODS OF IDENTIFYING AND SELECTING MAIZE PLANTS WITH RESISTANCE TO ANTHRACNOSE STALK ROT
#2326Methods for preparing nucleic acid libraries for sequencing
#2327METHOD TO DIAGNOSE A CMMRD
#2328METHOD FOR PREDICTING CANCER RISK VALUE BASED ON MULTI-OMICS AND MULTIDIMENSIONAL PLASMA FEATURES AND ARTIFICIAL INTELLIGENCE
#2329Biomarkers for Autism Spectrum Disorders
#2330METHODS AND COMPOSITIONS FOR DEVELOPING TARGET SPECIFIC EXOSOME AND GROWTH FACTOR PRODUCTS
#2331Method for preimplantation genetic screening of embryos for detection of structural rearrangements
#2332Sequence analysis using meta-stable nucleic acid molecules
#2333IMPROVED NUCLEIC ACID TARGET ENRICHMENT AND RELATED METHODS
#2334Off-Target Single Nucleotide Variants Caused by Single-Base Editing and High-Specificity Off-Target-Free Single-Base Gene Editing Tool
#2335Peptides and combination of peptides for use in immunotherapy against esophageal cancer and other cancers
#2336Peptides and combination of peptides for use in immunotherapy against esophageal cancer and other cancers
#2337Peptides and combination of peptides for use in immunotherapy against esophageal cancer and other cancers
#2338Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers
#2339TREATMENT OF DISEASE BASED ON IMMUNE CELL SEQUENCING
#2340Identification and treatment of T-cell epitopes of short H2A oncohistones
#2341P38 KINASE INHIBITORS REDUCE DUX4 AND DOWNSTREAM GENE EXPRESSION FOR THE TREATMENT OF FSHD
#2342APOE GENOTYPING IN CANCER PROGNOSTICS AND TREATMENT
#2343METHODS AND COMPOSITIONS FOR PROGNOSTIC AND/OR DIAGNOSTIC SUBTYPING OF PANCREATIC CANCER
#2344Monitoring health and disease status using clonotype profiles
#2345ELIMINATION PROBE-BASED METHOD FOR DETECTING NUMERICAL CHROMOSOMAL ABNORMALITIES, AND NUCLEIC ACID COMPOSITION FOR DETECTING NUMERICAL CHROMOSOMAL ABNORMALITIES
#2346Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers
#2347NEOANTIGENS IN CANCER
#2348TREATMENT AND DETECTION OF INHERITED NEUROPATHIES AND ASSOCIATED DISORDERS
#2349endophytes and related methods
#2350Double-flowering dwarf
#2351Detection of target nucleic acids using hybridization
#2352T CELL RECEPTOR AND B CELL RECEPTOR REPERTOIRE ANALYSIS SYSTEM, AND USE OF SAME IN TREATMENT AND DIAGNOSIS
#2353SINGLE-STRANDED NUCLEIC ACID FOR REAL-TIME DETECTION OF GENETIC VARIATION OF SINGLE TARGET GENE AND DETECTION METHOD USING THE SAME
#2354SNP MARKERS OF DRUG REDUCED SUSCEPTIBILITY RELATED EVOLUTIONARY BRANCHES OF CLOSTRIDIUM DIFFICILE, METHOD FOR IDENTIFYING STRAIN CATEGORY, AND USE THEREOF
#2355Methods for altering starch granule profile
#2356Method of ctDNA library construction and sequencing data analysis for simultaneously detecting multiple common mutations in liver cancer
#2357PROGRAMMABLE NUCLEASE IMPROVEMENTS AND COMPOSITIONS AND METHODS FOR NUCLEIC ACID AMPLIFICATION AND DETECTION
#2358Cas variants for gene editing
#2359NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST ESOPHAGEAL CANCER AND OTHER CANCERS
#2360NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST ESOPHAGEAL CANCER AND OTHER CANCERS
#2361NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST ESOPHAGEAL CANCER AND OTHER CANCERS
#2362NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST ESOPHAGEAL CANCER AND OTHER CANCERS
#2363Methods of diagnosing and treating anxiety disorder
#2364Methods of diagnosing and treating conduct disorder
#2365METHODS AND COMPOSITIONS FOR TREATING NON-ERK MAPK PATHWAY INHIBITOR-RESISTANT CANCERS
#2366SYSTEMS AND METHODS FOR IDENTIFYING RARE CELLS
#2367Methods and compositions for influenza a virus subtyping
#2368Methods and materials for using measles viruses
#2369Method and system for calculating tumor neoantigen burden
#2370METHODS AND SYSTEMS FOR DISEASE DETECTION
#2371WHEAT STEM RUST RESISTANCE GENES AND METHODS OF USE
#2372Methods for labeling DNA fragments to reconstruct physical linkage and phase
#2373Peptides and combination of peptides for use in immunotherapy against esophageal cancer and other cancers
#2374METHODS FOR DETERMINING THE QUALITY OF AN EMBRYO
#2375Multiplexed Parallel Analysis Of Targeted Genomic Regions For Non-Invasive Prenatal Testing
#2376Methods for high level multiplexed polymerase chain reactions and homogeneous mass extension reactions
#2377NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST ESOPHAGEAL CANCER AND OTHER CANCERS
#2378Nucleic acid detection combining amplification with fragmentation
#2379SINGLE-STRANDED OLIGONUCLEOTIDE PROBES FOR CHROMOSOME OR GENE COPY ENUMERATION
#2380Method of evaluating pre-cancerous or cancerous lesions for oral cancer
#2381Methods and systems for adjusting tumor mutational burden by tumor fraction and coverage
#2382METHODS FOR SIMULTANEOUS AMPLIFICATION OF TARGET LOCI
#2383DIAGNOSTIC METHOD
#2384PROCESSES AND KITS FOR IDENTIFYING ANEUPLOIDY
#2385Haploid inducers
#2386COMPOSITIONS AND METHODS COMPRISING HISTIDYL-TRNA SYNTHETASE SPLICE VARIANTS HAVING NON-CANONICAL BIOLOGICAL ACTIVITIES
#2387Peptides and combination of peptides for use in immunotherapy against esophageal cancer and other cancers
#2388METHODS OF DISEASE ACTIVITY PROFILING FOR PERSONALIZED THERAPY MANAGEMENT
#2389Human papilloma virus as predictor of cancer prognosis
#2390Hydrangea ‘SMNHPH’
#2391Methods and Compositions for Peronospora Resistance in Spinach
#2392PREDICTING IMMUNOGENICITY OF T CELL EPITOPES
#2393COMPOSITIONS, METHODS, AND SYSTEMS TO DETECT HEMATOPOIETIC STEM CELL TRANSPLANTATION STATUS
#2394BIOMARKERS AND USES THEREOF IN THE TREATMENT OF CHRONIC HBV INFECTION
#2395METHODS AND COMPOSITIONS FOR IMPUTING OR PREDICTING GENOTYPE OR PHENOTYPE
#2396Assay for by amplification and detection of AP65-1 gene
#2397InDel marker genotype database of and use in identity fingerprinting of germplasm resources
#2398METHOD FOR TESTING FOR SENSITIVITY OF CHEMOTHERAPY AGAINST COLORECTAL CANCER
#2399BTK MUTATION AND IBRUTINIB RESISTANCE
#2400DNA REFERENCE STANDARD AND USE THEREOF